EcoDrugPlus

Cyclin Dependent Kinase 7

Ensembl ID : ENSDORG00000026411
Gene Symbol: CDK7
3 Cross references
215 Possible Orthologues:

Cyclin Dependent Kinase 9

Ensembl ID : ENSDORG00000013328
Gene Symbol: CDK9
4 Cross references
207 Possible Orthologues:

Cyclin-Dependent Kinase 1

Ensembl ID : ENSDORG00000028394
Gene Symbol: LOC105996339
3 Cross references
244 Possible Orthologues:

Cysteinyl Leukotriene Receptor 1

Ensembl ID : ENSDORG00000025755
Gene Symbol: CYSLTR1
3 Cross references
181 Possible Orthologues:

Cytidine Deaminase

Ensembl ID : ENSDORG00000011900
Gene Symbol: CDA
2 Cross references
231 Possible Orthologues:

Cytochrome P450 26a1

Ensembl ID : ENSDORG00000006738
Gene Symbol: LOC105999373
4 Cross references
208 Possible Orthologues:

Cytochrome P450 3a5

Ensembl ID : ENSDORG00000027377
Gene Symbol: LOC105990905
2 Cross references
677 Possible Orthologues:

Cytochrome P450 3a9-Like

Ensembl ID : ENSDORG00000012448
Gene Symbol: LOC105990894
2 Cross references
630 Possible Orthologues:

Cytochrome P450 3a9-Like

Ensembl ID : ENSDORG00000003465
Gene Symbol: LOC106001866
2 Cross references
630 Possible Orthologues:

Diacylglycerol O-Acyltransferase 1

Ensembl ID : ENSDORG00000002336
Gene Symbol: DGAT1
3 Cross references
262 Possible Orthologues:

Dihydrofolate Reductase

Ensembl ID : ENSDORG00000024821
Gene Symbol: DHFR
4 Cross references
353 Possible Orthologues:

Dihydroorotate Dehydrogenase (Quinone)

Ensembl ID : ENSDORG00000013800
Gene Symbol: DHODH
4 Cross references
173 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).